Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of the drugs docetaxel and
capecitabine is effective in treating breast cancer patients.
Phase:
N/A
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center